Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMYOTROPHIC LATERAL SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04363684
What this trial is testing

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

Who this might be right for
Frontotemporal Lobar Degeneration (FTLD)Progressive Supranuclear Palsy (PSP)Corticobasal Degeneration (CBD)+11 more
Mayo Clinic 2,100
Not applicableAvailableNCT07088159
What this trial is testing

Intermediate-size Patient Population Expanded Access Protocol

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Spinogenix
Large-scale testing (Phase 3)UnknownNCT03800524
What this trial is testing

Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Humanitas Mirasole SpA 337
Testing effectiveness (Phase 2)Study completedNCT03828123
What this trial is testing

Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Bioinova, s.r.o. 26
Testing effectiveness (Phase 2)Study completedNCT01777646
What this trial is testing

Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Brainstorm-Cell Therapeutics 14
Large-scale testing (Phase 3)Study completedNCT03293069
What this trial is testing

Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Lille 372
Not applicableLooking for participantsNCT07202494
What this trial is testing

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)+7 more
Assistance Publique Hopitaux De Marseille 700
Large-scale testing (Phase 3)Study completedNCT01825551
What this trial is testing

The Effect of GCSF in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Tehran University of Medical Sciences 40
Not applicableLooking for participantsNCT00874783
What this trial is testing

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who this might be right for
Neurodegenerative Disorders
Hadassah Medical Organization 120
Not applicableLooking for participantsNCT07533903
What this trial is testing

Functional Outcomes and Control Using Synchron BCI - Australia

Who this might be right for
Neurologic DisorderNeurologic DiseasesMND (Motor Neurone DIsease)+4 more
Synchron, Inc. 10
Not applicableLooking for participantsNCT07259980
What this trial is testing

Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 125
Not applicableStudy completedNCT06315673
What this trial is testing

Digital Assessment of Speech and Fine Motor Control in ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy
Milton S. Hershey Medical Center 42
Early research (Phase 1)Study completedNCT03876002
What this trial is testing

Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET

Who this might be right for
Healthy VolunteersAmyotrophic Lateral Sclerosis
Molecular NeuroImaging 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688239
What this trial is testing

The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)ALS - Amyotrophic Lateral SclerosisALS
Tiziana Life Sciences LTD 44
Large-scale testing (Phase 3)Active Not RecruitingNCT04768972
What this trial is testing

FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Ionis Pharmaceuticals, Inc. 89
Large-scale testing (Phase 3)Study completedNCT00445172
What this trial is testing

A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Eisai Co., Ltd. 135
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Not applicableStudy completedNCT03489200
What this trial is testing

EH301 for the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Elysium Health 32
Not applicableStudy completedNCT01123200
What this trial is testing

An In-home Study of Brain Computer Interfaces

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Michigan 1
Testing effectiveness (Phase 2)Study completedNCT05039099
What this trial is testing

Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
AL-S Pharma 73
Next Page